Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levofloxacin otic solution - CEOLIA Pharma/NanoCarrier

Next Previous
Drug Profile

Levofloxacin otic solution - CEOLIA Pharma/NanoCarrier

Alternative Names: COMLEX; ENT-103; Otolaryngological therapeutic - Ceolia Pharma/NanoCarrier

Latest Information Update: 17 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CEOLIA Pharma; NanoCarrier
  • Class 3-ring heterocyclic compounds; Anti-infectives; Anti-inflammatories; Antibacterials; Fluorobenzenes; Fluoroquinolones; Morpholines; Nicotinic acids; Piperazines; Pyridones; Small molecules; Urinary anti-infective agents
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Otitis externa; Otitis media

Most Recent Events

  • 17 Sep 2025 Chemical structure information added.
  • 11 Apr 2023 Registered for Otitis externa in Japan (Otic) (NanoCarrier pipeline, April 2023)
  • 11 Apr 2023 Registered for Otitis media in Japan (Otic) (NanoCarrier pipeline, April 2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top